20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T24269 | KPT-251 | KPT251 | Others |
KPT-251 is a selective nuclear export inhibitor. | |||
TN4673 | (+)-Nortrachelogenin | Wikstromol | Apoptosis , HIV Protease , PI3K , Antifection |
(+)-Nortrachelogenin is a lignan isolated from Wikstroemia indica C.A. Meyer (Thymelaeaceae). (+)-Nortrachelogenin possesses antileukemic activity. | |||
TN1932 | Microhelenin C | Others | |
Microhelenin C has significant antileukemic activity. | |||
T5S1058 | Triptonide | PG 492,NSC 165677 | Apoptosis , Wnt/beta-catenin , Autophagy |
1. Triptonide (PG 492) is effective in the treatment of autoimmune diseases and has potent antileukemic and antitumor activities. 2. Triptonide possesses anti-inflammatory activity, upregulate the expression of IL-37, an... | |||
T25503 | Hisphen | Synonyms Hisfen,MD 2 | |
Hisphen shows antileukemic activity. | |||
TN2320 | Yadanzioside G | Others | |
Yadanzioside G has antileukemic activity. | |||
TN5266 | Yadanzioside F | Others | |
Yadanzioside F has antileukemic activity. | |||
TN5092 | Tagitinin F | Antifection | |
Tagitinin F possesses antileukemic activity; it also shows in vitro leishmanicidal activities against Leishmania braziliensis promastigotes and amastigotes. | |||
TN4027 | Eucannabinolide | Others | |
Eucannabinolide exhibits in vivo antileukemic activity. | |||
TN3796 | Dehydrobruceantinol | Others | |
Dehydrobruceantinol shows bitter taste and has antileukemic activity. | |||
T15472 | Hepsulfam | NCI 329680,ZINC01574758 | Others |
Hepsulfam is an anticancer agent. It also displays excellent antileukemic activity (a median IC50: 0.91 μg/mL in a panel of different tumors). | |||
T24492 | Moflomycin | F 860191,F-860191,F860191 | |
Moflomycin is an anthracycline derivative. It exhibits a higher antileukemic activity compared to other anthracyclines. | |||
TN5265 | Yadanzioside C | Others | |
Yadanzioside C has antileukemic activity. | |||
TN2319 | Yadanzioside A | Others | |
Yadanzioside A has antileukemic activity. | |||
TN3542 | Bruceantinoside A | Others | |
Bruceantinoside A has antileukemic activity. | |||
T25170 | Botryodiplodin | Cytostipin,Antibiotic PSX 1 | |
Botryodiplodin, an antibiotic, has antileukemic activity from Botryodiplodia theobromae. It has the property of turning the skin of the individual in various shades of pink 2-3 hrs after application. It is a toxic metabo... | |||
T22132 | PD 166326 | ||
PD166326, a pyridopyrimidine-type inhibitor of receptor tyrosine kinases, demonstrates antileukemic activity with IC50 values of 6 nM for Src and 8 nM for Abl. [1] [2]. | |||
T60559 | S-(N-PhenethylthiocarbaMoyl)-L-cysteine | ||
S-(N-PhenethylthiocarbaMoyl)-L-cysteine (PEITC-Cys) is an anticarcinogenic agent. S-(N-PhenethylthiocarbaMoyl)-L-cysteine shows antileukemic activity which inhibits DNA synthesis in HL60 cells [1]. S-(N-Phenethylthiocarb... | |||
T82774 | Caspase-3 activator 3 | Caspase | |
Caspase-3 activator 3 (compound 2h) effectively induces apoptosis in HL-60 and K562 cells by substantially activating caspase-3, demonstrating antileukemic activity with IC50 values of 42.89 μM and 33.61 μM, respectively... | |||
T73167 | HDAC-IN-49 | ||
HDAC-IN-49 is a potent, non-selective inhibitor of HDAC (HDAC), demonstrating IC50 values of 13 nM for HDAC1, 14 nM for HDAC2, 21 nM for HDAC3, 1880 nM for HDAC4, and 10 nM for HDAC6. This compound exhibits significant a... |